Revolution Medicines, Warrant Stock Total Debt
| RVMDW Stock | 0.10 0.01 9.09% |
Revolution Medicines, Warrant fundamentals help investors to digest information that contributes to Revolution Medicines,'s financial success or failures. It also enables traders to predict the movement of Revolution Stock. The fundamental analysis module provides a way to measure Revolution Medicines,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Revolution Medicines, stock.
Total Debt To Capitalization is likely to drop to 0.04 in 2025. Revolution | Total Debt |
Revolution Medicines, Warrant Company Total Debt Analysis
Revolution Medicines,'s Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Revolution Medicines, Total Debt | 135.84 M |
Most of Revolution Medicines,'s fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Revolution Medicines, Warrant is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revolution Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Revolution Medicines, is extremely important. It helps to project a fair market value of Revolution Stock properly, considering its historical fundamentals such as Total Debt. Since Revolution Medicines,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Revolution Medicines,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Revolution Medicines,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Revolution Total Debt Historical Pattern
Today, most investors in Revolution Medicines, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Revolution Medicines,'s growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Revolution Medicines, total debt as a starting point in their analysis.
Revolution Medicines, Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Revolution Short Long Term Debt Total
Short Long Term Debt Total |
|
Based on the latest financial disclosure, Revolution Medicines, Warrant has a Total Debt of 135.84 M. This is 95.06% lower than that of the Biotechnology sector and 58.17% lower than that of the Health Care industry. The total debt for all United States stocks is 97.45% higher than that of the company.
Revolution Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Revolution Medicines,'s direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Revolution Medicines, could also be used in its relative valuation, which is a method of valuing Revolution Medicines, by comparing valuation metrics of similar companies.Revolution Medicines, is currently under evaluation in total debt category among its peers.
Revolution Medicines, Current Valuation Drivers
We derive many important indicators used in calculating different scores of Revolution Medicines, from analyzing Revolution Medicines,'s financial statements. These drivers represent accounts that assess Revolution Medicines,'s ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Revolution Medicines,'s important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 2.6B | 1.8B | 1.9B | 3.2B | 7.3B | 7.7B | |
| Enterprise Value | 2.6B | 1.8B | 1.8B | 2.6B | 6.9B | 7.3B |
Revolution Fundamentals
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.19 | ||||
| Number Of Shares Shorted | 2.25 K | ||||
| Gross Profit | (592.23 M) | ||||
| EBITDA | (689.52 M) | ||||
| Net Income | (600.09 M) | ||||
| Total Debt | 135.84 M | ||||
| Book Value Per Share | 12.19 X | ||||
| Cash Flow From Operations | (557.44 M) | ||||
| Number Of Employees | 534 | ||||
| Beta | 1.46 | ||||
| Total Asset | 2.56 B | ||||
| Retained Earnings | (1.74 B) | ||||
| Working Capital | 2.16 B | ||||
| Net Asset | 2.56 B |
About Revolution Medicines, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Revolution Medicines, Warrant's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revolution Medicines, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revolution Medicines, Warrant based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Revolution Stock Analysis
When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.